Results 261 to 270 of about 1,109,000 (367)

CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives

open access: yesClinical and Translational Medicine, Volume 15, Issue 12, December 2025.
1. Chimeric antigen receptor T (CAR‐T) therapy has made some progress in the treatment of acute myeloid leukaemia (AML), among which C‐type lectin‐like molecule‐1 (CLL1) CAR‐T‐cell therapy has shown certain efficacy in the treatment of relapsed/refractory (R/R) AML. However, 30% of patients exhibit primary treatment resistance. Key factors limiting the
Rui Zhang   +3 more
wiley   +1 more source

Predictive Factors of Non-Elevation of Carcinoembryonic Antigen 125 in Acute Heart Failure. [PDF]

open access: yesLife (Basel)
López-Vilella R   +8 more
europepmc   +1 more source

The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence - A systematic review.

open access: yesInternational Journal of Surgery, 2016
C. Sørensen   +4 more
semanticscholar   +1 more source

Curcumin's Therapeutic Potential in Ovarian Cancer: Current Insights and Future Perspectives

open access: yesFood Science &Nutrition, Volume 13, Issue 12, December 2025.
This review provides an overview of ovarian cancer, examines curcumin's emerging role in its treatment, identifies existing research gaps, and outlines a roadmap for future studies aimed at fully exploring curcumin's therapeutic potential in the management of ovarian cancer.
Smirnova Elena   +7 more
wiley   +1 more source

Predictive value of perioperative carcinoembryonic antigen changes for recurrence in non-small cell lung cancer. [PDF]

open access: yesTransl Lung Cancer Res
Sun H   +10 more
europepmc   +1 more source

Integrated Transcriptomic and Metabolomic Analysis Revealed That Tryptophan Metabolism–Related Metabolites Are Biomarkers of Trastuzumab Resistance

open access: yesJournal of Clinical Laboratory Analysis, Volume 39, Issue 23, December 2025.
Tryptophan metabolism‐related metabolic signature and transcription signature were explored, and four metabolites were determined as potential metabolic biomarkers of trastuzumab resistance. Then, the metabolic signature of potential metabolic biomarkers in serum discriminated TR patients from TS patients.
Xinxin Si   +6 more
wiley   +1 more source

Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen [PDF]

open access: yes, 1988
Hinoda, Yuji   +5 more
core  

Carcinoembryonic antigen-producing adrenal adenoma resected using combined lateral and anterior transperitoneal laparoscopic surgery

open access: hybrid, 2007
Tomohide Hori   +15 more
openalex   +2 more sources

A Seer‐Based Analysis of Survival Predictors in Stage I Colorectal Adenocarcinomas

open access: yesJournal of Surgical Oncology, Volume 132, Issue 8, Page 1320-1330, December 15, 2025.
ABSTRACT Background We assessed predictors of overall (OS) and cancer‐specific survival (CSS) in stage I colorectal cancer (CRC). Methods Retrospective analysis of patients with stage I colon or rectal adenocarcinomas from the SEER database (2010–2020) Survival was assessed using Kaplan‐Meier statistics and multivariable Cox regression analyses.
Sameh Hany Emile   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy